Apellis Pharmaceuticals Inc (APLS)

08:20 AM

What are Apellis Pharmaceuticals Inc. company’s key revenue driversLow Risk Report For Consistent Profits - jammulinksnews.com

08:20 AM

06:02 AM

How many analysts rate Apellis Pharmaceuticals Inc. as a “Buy”Invest confidently with proven investment plans - jammulinksnews.com

06:02 AM

05:35 AM

What makes Apellis Pharmaceuticals Inc. stock price move sharplyCapitalize on strong market momentum - jammulinksnews.com

05:35 AM

02:56 AM

Is it the right time to buy Apellis Pharmaceuticals Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com

02:56 AM

02:46 AM

How does Apellis Pharmaceuticals Inc. compare to its industry peersAchieve exceptional returns with expert guidance - jammulinksnews.com

02:46 AM

Jul 27, 2025

How does Apellis Pharmaceuticals Inc. generate profit in a changing economyAchieve exceptional returns with expert guidance - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

When is Apellis Pharmaceuticals Inc. stock expected to show significant growthDiscover dynamic stocks ready to soar - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Will Apellis Pharmaceuticals Inc. stock benefit from interest rate changesFree Best Performing Stock Suggestions - metal.it

Jul 27, 2025

Jul 27, 2025

What is Apellis Pharmaceuticals Inc. company’s growth strategyExceptional profit velocity - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What institutional investors are buying Apellis Pharmaceuticals Inc. stockHigh-yield trading alerts - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Apellis signs royalty purchase deal with Sobi for Aspaveli - MSN

Jul 27, 2025

Jul 25, 2025

Is Apellis Pharmaceuticals Inc. a good long term investmentOver 200% growth - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What analysts say about Apellis Pharmaceuticals Inc. stockSky-high return potential - Autocar Professional

Jul 25, 2025

Jul 24, 2025

Apellis Pharmaceuticals to Host Conference Call on July 31, 2025 - GuruFocus

Jul 24, 2025

Jul 24, 2025

Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results - The Manila Times

Jul 24, 2025

Jul 24, 2025

Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results | APLS Stock News - GuruFocus

Jul 24, 2025

Jul 24, 2025

Apellis Pharmaceuticals to Host Conference Call for Q2 2025 Financial Results on July 31 - Nasdaq

Jul 24, 2025

Jul 24, 2025

Fierce Biotech Layoff Tracker 2025: Rocket ejects 30% of staffers; Flagship's Tessera and Generate Bio trim teams - Fierce Biotech

Jul 24, 2025

Jul 23, 2025

Complement 3 Glomerulopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | NovelMed Therapeutics, Apellis Pharma, Novartis, Amyndas Pharma - Barchart.com

Jul 23, 2025

Jul 23, 2025

Apellis Pharmaceuticals Inc. Stock Analysis and ForecastOutstanding trading profits - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What drives Apellis Pharmaceuticals Inc. stock priceExceptional market performance - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Intermediate Age-Related Macular Degeneration Market Research 2025-2035 Featuring Novartis, Allegro Ophthalmics, and Apellis PharmaceuticalsResearchAndMarkets.com - FinancialContent

Jul 21, 2025

Jul 18, 2025

Baird Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Raises Target Price to $50 - 富途牛牛

Jul 18, 2025

Jul 18, 2025

Apellis Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) - Benzinga

Jul 18, 2025

Jul 16, 2025

APLS Stock Update: B of A Securities Raises Price Target | APLS - GuruFocus

Jul 16, 2025

Jul 16, 2025

Apellis price target raised to $24 from $23 at BofA - TipRanks

Jul 16, 2025

Jul 15, 2025

Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting - The Manila Times

Jul 15, 2025

Jul 15, 2025

Apellis Reveals 48-Month SYFOVRE Data: 5 Key Studies Show Promise for Geographic Atrophy Treatment - Stock Titan

Jul 15, 2025

Jul 14, 2025

H.C. Wainwright reiterates Buy rating on Apellis Pharmaceuticals stock By Investing.com - Investing.com Canada

Jul 14, 2025

Jul 14, 2025

How the (APLS) price action is used to our Advantage - news.stocktradersdaily.com

Jul 14, 2025

Jul 11, 2025

Apellis Pharmaceuticals (APLS) Receives a Buy from Cantor Fitzgerald - The Globe and Mail

Jul 11, 2025